First allergy vaccine registered in Russia
The Ministry of Health of the Russian Federation has officially registered a new drug designed to combat allergies. This is a significant event for millions of Russians who suffer annually from seasonal bodily reactions to plant pollen.
The new medication was developed specifically for the prevention and treatment of allergic rhinoconjunctivitis. This condition often manifests as a runny nose, itchy eyes, and tearing, which significantly reduces the quality of life for patients during the spring and summer periods.
The drug's mechanism of action is based on the method of allergen-specific immunotherapy. Unlike standard antihistamines, which only temporarily relieve symptoms, the vaccine helps the body "get used" to the allergen and stop reacting to it so acutely.
Experts note that the emergence of such a vaccine is a major step forward for domestic medicine. Patients will now have access to a modern treatment method aimed at eliminating the root cause of the allergy, rather than just its external manifestations.
It is expected that the drug will be available in medical institutions across the country in the near future. Doctors recommend that patients suffering from pollinosis consult with specialists to determine if this type of therapy is suitable for them.